Webinar: Clostridium difficile infection management and outcomes: considerations in a resource-limited setting
20 November 2018 14:00 CET, Online
C. difficile infection (CDI) is understudied in low-resource settings. A recent epidemiology, management and outcomes study in South Africa found a significant risk of in-hospital mortality in patients who tested positive for C. difficile. Opportunities to improve management will be described. While metronidazole was found to be the most common initial therapy, recent evidence proves vancomycin is more efficacious. Considerations for the clinical use of metronidazole compared with vancomycin in a resource-limited setting will be presented.
Speakers: Laurel Legenza, PharmD, MS — interim director of global health and an assistant scientist at the University of Wisconsin-Madison, School of Pharmacy, Madison, USA Renier Coetzee, BPharm, MPharm, PharmD — senior lecturer at the University of the Western Cape, South Africa School of Pharmacy
Chair: John Hertig, PharmD, MS, CPPS — associate professor, Butler University College of Pharmacy and Health Sciences, Indianapolis, USA